| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 15 Jun 2021 | 26 Jun 2020 | 15 Jun 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 15 Jun 2021 | 5 Apr 2019 | 15 Jun 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 8 Jun 2021 | 9 Dec 2020 | 8 Jun 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 8 Jun 2021 | 4 Nov 2020 | 8 Jun 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 1 Jun 2021 | 30 Jun 2020 | 1 Jun 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 1 Jun 2021 | 26 Jun 2020 | 1 Jun 2021 |
| Utility: Peptides and combination thereof for use in the immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 1 Jun 2021 | 18 Feb 2020 | 1 Jun 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 25 May 2021 | 10 Dec 2020 | 25 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 25 May 2021 | 4 Nov 2020 | 25 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 25 May 2021 | 4 Nov 2020 | 25 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 25 May 2021 | 6 May 2020 | 25 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 18 May 2021 | 29 Jun 2020 | 18 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 18 May 2021 | 24 Jun 2020 | 18 May 2021 |
| Utility: Peptides and combination thereof for use in the immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 18 May 2021 | 28 Feb 2020 | 18 May 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 11 May 2021 | 30 Jun 2020 | 11 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 11 May 2021 | 26 Jun 2020 | 11 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 4 May 2021 | 4 Nov 2020 | 4 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Filling date: 9 Sep 2025 Issue date: 4 May 2021 | 18 Feb 2020 | 4 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 4 May 2021 | 13 Feb 2019 | 4 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 9 Sep 2025 Issue date: 6 Apr 2021 | 9 Dec 2016 | 6 Apr 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 23 Mar 2021 | 18 Sep 2019 | 23 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 16 Mar 2021 | 26 Jun 2020 | 16 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 9 Sep 2025 Issue date: 16 Mar 2021 | 24 Jun 2020 | 16 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 9 Sep 2025 Issue date: 16 Mar 2021 | 12 Jun 2020 | 16 Mar 2021 |
| Utility: *03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 16 Mar 2021 | 19 Jun 2019 | 16 Mar 2021 |
| Utility: Personalized immunotherapy against several neuronal and brain tumors Filling date: 9 Sep 2025 Issue date: 16 Mar 2021 | 3 Nov 2014 | 16 Mar 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 9 Sep 2025 Issue date: 9 Mar 2021 | 2 Aug 2016 | 9 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers Filling date: 9 Sep 2025 Issue date: 2 Mar 2021 | 30 Sep 2020 | 2 Mar 2021 |
| Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 2 Mar 2021 | 29 Jun 2020 | 2 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 2 Mar 2021 | 29 Jun 2020 | 2 Mar 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 9 Sep 2025 Issue date: 2 Mar 2021 | 5 Jun 2020 | 2 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 9 Sep 2025 Issue date: 2 Mar 2021 | 6 Aug 2018 | 2 Mar 2021 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 9 Sep 2025 Issue date: 23 Feb 2021 | 30 Sep 2020 | 23 Feb 2021 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 23 Feb 2021 | 9 Jul 2018 | 23 Feb 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 23 Feb 2021 | 22 Apr 2016 | 23 Feb 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 9 Sep 2025 Issue date: 16 Feb 2021 | 16 Jun 2020 | 16 Feb 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 9 Sep 2025 Issue date: 16 Feb 2021 | 2 Aug 2016 | 16 Feb 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 2 Feb 2021 | 30 Jun 2020 | 2 Feb 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 9 Sep 2025 Issue date: 2 Feb 2021 | 16 Jun 2020 | 2 Feb 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 2 Feb 2021 | 6 May 2020 | 2 Feb 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 9 Sep 2025 Issue date: 2 Feb 2021 | 13 Dec 2019 | 2 Feb 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 9 Sep 2025 Issue date: 2 Feb 2021 | 2 Aug 2016 | 2 Feb 2021 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 30 Sep 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 11 Sep 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 11 Sep 2020 | 26 Jan 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
